--- title: "Cronos Group (CRON) stock listing, news and investor profile" url: "https://aibio.space/companies/cronos/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Cronos Group Inc. (NASDAQ: CRON), United States. Listing facts, related biotech companies and news on aibio.space." --- CRON Cronos Group Inc. NASDAQ · United States # Cronos Group (CRON) news Cronos Group Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker CRON, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Cronos Group news We have not published a story on Cronos Group yet. When there is news, it will appear here. ## Cronos Group at a glance - **Ticker**: CRON - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $797.0 million ### Related companies - [Devonian Health Group](https://aibio.space/companies/devonian-health-dvhgf/) OTC: DVHGF - [Brainsway](https://aibio.space/companies/brainsway/) NASDAQ: BWAY - [STRYKER CORP](https://aibio.space/companies/stryker/) NYSE: SYK - [Cryoport](https://aibio.space/companies/cryoport/) NASDAQ: CYRX - [UL Solutions](https://aibio.space/companies/ul-solutions/) NYSE: ULS - [Rafael Holdings](https://aibio.space/companies/rafael/) NYSE: RFL - [Schrodinger](https://aibio.space/companies/schrodinger/) NASDAQ: SDGR - [SMITH & NEPHEW](https://aibio.space/companies/smith-nephew/) NYSE: SNN ### Also on NASDAQ - [TriSalus Life Sciences](https://aibio.space/companies/trisalus-life-sciences/) TLSI - [Kazia Therapeutics](https://aibio.space/companies/kazia-therapeutics/) KZIA - [Akebia Therapeutics](https://aibio.space/companies/akebia-therapeutics/) AKBA - [Vogenx](https://aibio.space/companies/vogenx/) VOGX - [EDAP TMS SA](https://aibio.space/companies/edap-tms/) FOCL - [ENDRA Life Sciences](https://aibio.space/companies/endra-life-sciences/) NDRA ## Cronos Group annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$146.6 million](https://www.sec.gov/Archives/edgar/data/1656472/000165647226000016/) | [$117.6 million](https://www.sec.gov/Archives/edgar/data/1656472/000165647226000016/) | | Research and development | [$4.4 million](https://www.sec.gov/Archives/edgar/data/1656472/000165647226000016/) | [$4.2 million](https://www.sec.gov/Archives/edgar/data/1656472/000165647226000016/) | | Net income (loss) | [-$9.4 million](https://www.sec.gov/Archives/edgar/data/1656472/000165647226000016/) | [$41.1 million](https://www.sec.gov/Archives/edgar/data/1656472/000165647226000016/) | | Cash from operations | [$25.9 million](https://www.sec.gov/Archives/edgar/data/1656472/000165647226000016/) | [$18.8 million](https://www.sec.gov/Archives/edgar/data/1656472/000165647226000016/) | | Cash and equivalents | [$791.8 million](https://www.sec.gov/Archives/edgar/data/1656472/000165647226000051/) | [$858.8 million](https://www.sec.gov/Archives/edgar/data/1656472/000165647226000016/) | | Short-term investments | [$40.0 million](https://www.sec.gov/Archives/edgar/data/1656472/000165647226000051/) | [$0](https://www.sec.gov/Archives/edgar/data/1656472/000165647226000016/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $467.0 million, plus short-term investments of $330.0 million, $797.0 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Cronos Group What is the ticker symbol of Cronos Group? Cronos Group Inc. trades under the ticker CRON on NASDAQ. Where is Cronos Group listed? Cronos Group Inc. is listed on NASDAQ. Which country or territory is Cronos Group listed under? Our directory records Cronos Group Inc. under United States. Does aibio.space cover Cronos Group? aibio.space lists Cronos Group Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What was Cronos Group's revenue last year? $146.6 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Cronos Group profitable? Cronos Group Inc. reported a net loss of $9.4 million for the fiscal year ended Dec 31, 2025, and generated $25.9 million of cash from operations, per its annual report to the SEC. How much does Cronos Group spend on research and development? $4.4 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Cronos Group have? $797.0 million in cash and short-term investments at Jun 30, 2026, per its 10-Q. ## Investor discussion: Cronos Group Members talk about Cronos Group (CRON). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Cronos Group, newest first. Each line links the filing it comes from. 1. 2026-10-15 Mergers Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 1.01,2.01,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1656472/000165647226000061/exhibit991-pressreleasexcr.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:CRON on TradingView](https://www.tradingview.com/symbols/NASDAQ-CRON/). ## Listing details Cronos Group Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker CRON, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Cronos Group Inc. - **Ticker**: CRON - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/cronos/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Cronos Group (CRON) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/cronos/